Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy costs in the UK private market typically range from around £149 to £375 per month depending on the dose and provider, with Novo Nordisk's list price rising significantly across the sector since 2025. That figure is for the medicine itself — a prescription-only treatment requiring clinical assessment before any prescription can be issued. The monthly cost you see advertised is rarely the full picture, and understanding what sits behind the price matters as much as the number itself. If you are comparing providers, the right question is not just how much, but what the price actually covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception people bring to this topic is that finding the lowest advertised price means they have found the best deal. It is understandable, the numbers look simple when they are lined up on a comparison page. In reality, that headline figure frequently excludes the consultation fee (charged separately at some providers), a prescription fee on top, delivery costs, and any clinical support if something goes wrong mid-treatment. Add those in and a seemingly modest monthly price can climb considerably. Some providers also charge separately for dose-increase reviews or restrict aftercare to a paid tier.
Wegovy (semaglutide) is a Prescription-Only Medicine, which means every course of treatment must begin with a proper clinical assessment by a qualified prescriber. That assessment is not optional paperwork, it is what makes the prescription legal and safe. More about how Wegovy works and who it is licensed for is on our main semaglutide page, and the NHS medicines entry for semaglutide covers the clinical basis in plain language. The point here is simple: a consultation has a real cost, and providers who do not show it upfront are showing you an incomplete price.
One transparent wegovy price per month that includes everything (consultation, prescription, medicine, delivery and aftercare) is a more honest comparison point than a stripped-back per-pen price sitting next to a list of add-ons. That is the standard worth holding providers to.
Several factors explain why private Wegovy prices differ so widely. Dose is the primary driver: the maintenance schedule runs from 0.25 mg through to 2.4 mg weekly, titrated by the prescriber over several months, and higher doses carry a higher list price. The MHRA approved a higher 7.2 mg maintenance dose in early 2026, which sits above the previous 2.4 mg ceiling, you can read more about how Wegovy's pricing maps across doses for a fuller breakdown.
Provider overhead is the second factor. A GPhC-registered pharmacy with a dedicated prescribing team, identity verification, video-based weight checks and daily clinical reviews carries higher running costs than an automated platform. Those costs are real and they exist for good reason. NICE's guidance on semaglutide for weight management (TA875) sets out the clinical framework, including the importance of multidisciplinary support alongside the medicine, guidance that shapes how responsible providers structure their service.
Novo Nordisk's list pricing also shifted meaningfully during 2024 and 2025, with private market prices adjusting accordingly. Any figures you saw quoted eighteen months ago are likely out of date. Our UK Wegovy cost breakdown reflects current market context. For those curious about NHS access, NHS pricing and eligibility for Wegovy is a separate question worth reading, waiting lists through specialist services remain long in most areas.
At nume, one price covers the consultation, the prescription, the medicine, free next-working-day delivery via DPD, and aftercare seven days a week. There are no add-on fees, no subscription tying you in, and every repeat order goes through a fresh clinical review before dispatch. That last point is not a formality, it is how responsible prescribing works for a medicine in this class.
We are not the cheapest option in this market, and that is a deliberate choice. The clinical infrastructure behind same-day prescriber review, photo-ID verification, live weight confirmation and GP notification does not come for free. What it does mean is that when your prescription is issued, it reflects an actual clinical assessment of your specific situation, not a form processed by software. Our GPhC pharmacy registration (number 9012878) is publicly verifiable on the GPhC register. Our clinical team is named and accountable. That is the structure behind the price.
Current treatment pricing, shown clearly on our treatment page, reflects everything included. There is nothing hidden.
Price is a reasonable thing to think about when choosing a service. But for a Prescription-Only Medicine like Wegovy, the cheapest listing answers a different question than the one that actually protects you. The MHRA has warned publicly about counterfeit weight-loss pens sold online, including fake pens that have been found to contain insulin instead of semaglutide. Seizures of illegally traded medicines have involved approximately 20 million doses with a street value estimated around £45 million. If you want to understand what goes into wegovy costs across the private market, including why prices sit where they do, our dedicated page covers what you are actually paying for and where the differences come from.
The safer question is: does this provider hold a GPhC registration I can verify? Does a real prescriber review my consultation? Is there clinical support if I have concerns during treatment? Our FAQs page covers the most common questions about our process, and the broader context of weight-loss treatment options may help if you are still deciding which route suits you. For anything else, our support team is available seven days a week.
A small monthly saving is not the measure that keeps you safe. Genuine medicine, from a verified prescriber, through a registered pharmacy, that is the metric worth optimising for. Start your free consultation and our prescribers will assess whether Wegovy is clinically suitable for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.